Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Welcome to BioNTech’s Fourth Quarter and Full-Year 2024 Earnings Call. I would like to hand the call over to Michael Horowicz, Director of ...

Kennedy Jr., moved closer to the job after a favorable vote by a Senate panel. BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties BioNTech has entered into two separate ...

The settlement payment of $467 million related to a contractual dispute with the University of Pennsylvania is expected to be reflected in the Company's second quarter 2025 financial results. In ...

Pfizer and BioNTech did not challenge the validity ... Investors care about profitability, and if a company has to pay out a big settlement from its cash reserves, that limits the ability to ...

Wall Street is assessing the crucial monthly jobs report amid market uncertainty driven by President Donald Trump's volatile ...

In 2009, Pfizer faced more than $2 billion in legal settlement payments over marketing ... vaccine approved – via its collaboration with BioNTech – it feels like we're only on the cusp of ...

Themba Hadebe/AP In May 2020, Themba Hadebe photographed people as they lined up to receive food donations at the Iterileng settlement near ... to receive the Pfizer/BioNtech Covid-19 vaccine.